Veru Inc. Announces FDA Support in Request for Emergency Use Authorization
Veru Inc. (NASDAQ: VERU) today announced that the U.S. Food and Drug Administration has agreed that the efficacy and safety data from Veru’s completed Phase 3 clinical study sufficient to support the submission of a request for Emergency Use Authorization...